14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ANTH
Delisted

Anthera Pharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.000001
+0 (+0%)
At Close: May 27, 2022
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Dec 04, 2019 $0.0341 $0.0430 $0.0341 $0.0349 28 943
Dec 03, 2019 $0.0335 $0.0430 $0.0335 $0.0430 7 308
Dec 02, 2019 $0.0335 $0.0430 $0.0335 $0.0416 5 955
Nov 29, 2019 $0.0415 $0.0430 $0.0415 $0.0430 20 089
Nov 27, 2019 $0.0271 $0.0437 $0.0271 $0.0400 71 608
Nov 26, 2019 $0.0326 $0.0399 $0.0300 $0.0361 24 034
Nov 25, 2019 $0.0326 $0.0400 $0.0326 $0.0400 16 677
Nov 22, 2019 $0.0326 $0.0400 $0.0326 $0.0356 15 879
Nov 21, 2019 $0.0345 $0.0400 $0.0338 $0.0400 4 798
Nov 20, 2019 $0.0350 $0.0440 $0.0326 $0.0400 55 843
Nov 19, 2019 $0.0391 $0.0441 $0.0311 $0.0400 9 921
Nov 18, 2019 $0.0322 $0.0450 $0.0322 $0.0450 21 420
Nov 15, 2019 $0.0347 $0.0450 $0.0312 $0.0450 58 162
Nov 14, 2019 $0.0356 $0.0415 $0.0312 $0.0415 25 318
Nov 13, 2019 $0.0321 $0.0400 $0.0316 $0.0400 40 726
Nov 12, 2019 $0.0340 $0.0400 $0.0340 $0.0400 4 616
Nov 11, 2019 $0.0497 $0.0497 $0.0370 $0.0470 21 091
Nov 08, 2019 $0.0450 $0.0497 $0.0340 $0.0470 44 892
Nov 07, 2019 $0.0400 $0.0460 $0.0312 $0.0450 57 085
Nov 06, 2019 $0.0500 $0.0500 $0.0400 $0.0500 7 208
Nov 05, 2019 $0.0360 $0.0500 $0.0360 $0.0420 31 764
Nov 04, 2019 $0.0360 $0.0500 $0.0300 $0.0400 97 965
Nov 01, 2019 $0.0375 $0.0500 $0.0375 $0.0483 14 724
Oct 31, 2019 $0.0400 $0.0500 $0.0400 $0.0460 5 743
Oct 30, 2019 $0.0400 $0.0456 $0.0390 $0.0456 49 484
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT